Published TCIMAIL newest issue No.197 | New tool "TCI SpectraViewer" | [TCIPracticalExample] The Synthesis of Rubicene... | Product Document Searching Made Easy by 2D Code!
Maximum quantity allowed is 999
CAS RN: 63659-19-8 | Product Number: B4474
Betaxolol Hydrochloride

Purity: >98.0%(HPLC)
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
50MG |
₹8,500.00
|
3 | 18 |
|
250MG |
₹10,400.00
|
2 | 24 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | B4474 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__1__8H__2__9NO__3·HCl = 343.89 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 63659-19-8 |
Related CAS RN | 63659-18-7 |
Reaxys Registry Number | 5182512 |
PubChem Substance ID | 253662283 |
Merck Index (14) | 1182 |
MDL Number | MFCD00242959 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(with Total Nitrogen) | min. 97.0 % |
Melting point | 113.0 to 117.0 °C |
NMR | confirm to structure |
Melting Point | 115 °C |
Solubility (slightly sol. in) | Acetone |
Solubility (insoluble in) | Ether |
Pictogram |
![]() ![]() |
Signal Word | Warning |
Hazard Statements | H302 : Harmful if swallowed. H361 : Suspected of damaging fertility or the unborn child. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. P405 : Store locked up. |
RTECS# | UA9823000 |
References
- Synthesis of a series of compounds related to betaxolol, a new β1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases
- Betaxolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension
- Betaxolol, a β1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels
- In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent
- Topically applied betaxolol attenuates ischemia-induced effects to the rat retina and stimulates BDNF mRNA
- Screening for library-assisted identification and fully validated quantification of 22 beta-blockers in blood plasma by liquid chromatography-mass spectrometry with atmospheric pressure chemical ionization
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.